Trial Profile
Phase III Adjuvant Trial in Pancreatic Cancer Comparing 5FU and D-L-Folinic Acid vs. Gemcitabine.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Jun 2023
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Fluorouracil; Folinic acid
- Indications Adenocarcinoma; Pancreatic cancer; Periampullary cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms ESPAC-3
- 10 Apr 2021 Results assessing digital quantification of GATA6 immunohistochemistry association with overall survival and pancreatic adenocarcinoma specimens were obtained from patients enrolled in two clinical studies: ESPAC-3 and ESPAC-4 presented at the 112th Annual Meeting of the American Association for Cancer Research
- 08 Mar 2018 Results of an analysis assessing the intra-tumoural dihydropyrimidine dehydrogenase expression status in patient population from this trial (n= 238), published in the British Journal of Cancer.
- 11 Jul 2012 Results published in JAMA: the Journal of the American Medical Association.